Skip to main content

J&J To Compensate Indian Patients Over Faulty Hip Implant

J&J To Compensate Indian Patients Over Faulty Hip Implant

J&J To Compensate Indian Patients Over Faulty Hip Implant

Introduction

According to a formula devised by a government panel of experts, Indian patients who suffered severe complications allegedly due to the faulty hip implants sold by Johnson and Johnson (J&J) might receive ₹1.2 crore each in compensation.

The formula is yet to be approved by the Indian Health Ministry. Two people aware of the development stated the compensation amount would vary between ₹33 lakh to ₹1.2 crore depending on the percentage of disability and age of the person. The expert committee suggested using the Indian Disability Evaluation and Assessment Scale (IDEAS) to assess and certify the disability in patients. According to statements from related people, if the disability is on a higher scale (40-45%) and the patient underwent hip surgery at a young age then the amount of compensation would increase. The amount would be increased after considering future expenses, disturbance of routine and mental agony. After the health ministry approves the formula, the compensation process would begin. This is the first attempt by the Indian government to compensate patients who suffered due to substandard treatment. About 100 individuals who were implanted with J&J's ASR hip implant have already approached the committee asking for compensation for their damages.

Many other manufacturers in the United States are also charged with lawsuits over complications related to ASR and Pinnacle hip implants. DePuy faces more than 20,000 lawsuits over complications related to their hip implants. About 28,000 lawsuits have been filed against various hip implant makers accusing defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew of hiding health hazards of the defective hip implants.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!